Management of chronic heart failure in the older population

Journal of Geriatric Cardiology

Volumn 11, Issue 4, 2014, Pages 329-337

  Azad, Nahid ^a   Lemay, Genevieve ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Coronary artery disease; Diabetes; Elderly patient; Heart failure; Hypertension; Management

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANDESARTAN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METOLAZONE; NEBIVOLOL; PERINDOPRIL; PLACEBO; SPIRONOLACTONE;

AGED; ANEMIA; ANOREXIA; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; COGNITION; COMORBIDITY; CONFUSION; CORONARY ARTERY DISEASE; COUGHING; DIABETES MELLITUS; DRUG MEGADOSE; HEALTH CARE QUALITY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HOME MONITORING; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; MORBIDITY; PALLIATIVE THERAPY; PHYSIOTHERAPY; PREVALENCE; QUALITY OF LIFE; REVIEW; RISK FACTOR; SEX DIFFERENCE; STRESS INCONTINENCE; SYSTOLIC HEART FAILURE; TERMINAL CARE; VISUAL DISORDER;

EID: 84920544421     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: 10.11909/j.issn.1671-5411.2014.04.008     Document Type: Review

References (59)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics - 2011 update. Circulation 2011; 123: e18-e209.
2. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics 2010 update: a report from the American Heart Association. Circulation 2010; 121: 948-954.
3. Husaini BA, Mensah GA, Sawyer D, et al. Race, sex, and age differences in heart failure-related hospitalizations in a southern State: implications for prevention. Circ Heart Fail 2011; 4: 161-169.
4. Johansen H, Strauss B, Arnold JMO, et al. On the rise: The current and projected future burden of congestive heart failure hospitalization in Canada. Can J Cardiol 2003; 19: 430-435.
5. McCullough PA, Philbin EF, Spertus JA, et al. Confirmation of a heart failure epidemic: findings from the Ressource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 2002; 39: 60-69.
6. Wong CY, Chaudhry SI, Desai MM, et al. Trends in co- morbidity, disability, and polypharmacy in heart failure. Am J Med 2011; 124: 136-143.
7. Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure-the Framingham Heart Study. Circulation 2002; 106: 3068-3072.
8. Stein GY, Kremer A, Shochat T, et al. The diversity of heart failure in a hospitalized population: the role of age. J Card Fail 2012; 18: 645-653.
9. Bibbins-Domingo K, Lin F, Vittinghoff E, et al. Predictors of heart failure among women with coronary disease. Circulation 2004; 110: 1424-1430.
10. Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: Framingham Study. J Am Coll Cardiol 1993; 22(4 SupplA): 6A-13A.
11. Azad N, Kathiravelu A, Hebert P, et al. Sex differences in the etiology of heart failure. A Systematic Review. J Geriatr Cardiol 2011; 8: 15-23.
12. Bahtia RS, Tu J, Lee D, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006; 355: 260-269.
13. Braunstein JB, Anderson GF, Gerstenblith G, et al. Non cardiac comorbidity increases preventable hospitalizations and mortality among medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 2003; 42: 1226-1233.
14. From AM, Leibson CL, Bursi F, et al. Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med 2006; 119: 591-599.
15. Lazzarini V, Mentz RJ, Fiuzat M, et al. Heart failure in elderly patients: distinctive features and unresolved issues. Eur J Heart Fail 2013; 15: 717-723.
16. Metra M, Brutsaert D, Dei Cas L, et al. Acute heart failure: epidemiology, classification and pathophysiology. In The ESC textbook of intensive and acute cardiac care: Oxford University Press: Oxford/New York, USA, 2011; 479-490.
17. Gheorghiade M, Zannad F, Sopko G, et al. International working group on acute heart failure syndromes. Acute heart failure syndromes: current state and framework for future research. Circulation 2005; 112: 3958-3968.
18. Oudejans I, Mosterd A, Bloemen JA, et al. Clinical evaluation of geriatric outpatients with suspected heart failure: value of symptoms, signs, and additional tests. Eur J Heart Fail 2011; 13: 518-527.
19. Wang TJ, Evans JC, Benjamin EJ, et al. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 2003; 108: 977-982.
20. Dodson JA, Truong TTN, Towle VR, et al. Cognitive impairment in older adults with heart failure: prevalence, documentation, and impact on outcomes. Am J Med 2013; 126: 120.
21. McLennan SN, Pearson SA, Cameron J, et al. Prognostic importance of cognitive impairment in chronic heart failure patients: does specialist management make a difference? Eur J Heart Fail 2006; 8: 494-501.
22. Cameron J, Worrall-Carter L, Page K, et al. Does cognitive impairment predict poor self-care in patients with heart failure? Eur J Heart Fail 2010; 12: 508-515.
23. Ross JS, Chen J, Lin Z, et al. Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail 2010; 3: 97-103.
24. Cameron J, Ski CF, Thompson DR. Cognitive impairment in chronic heart failure and the need for screening. Am J Cardiol 2011; 107: 1547-1548.
25. Man JP, Jugdutt BI. Systolic heart failure in the elderly: optimizing medical management. Heart Fail Rev 2012; 17(4-5): 563-571.
26. Rich MW. Pharmacotherapy of heart failure in the elderly: adverse events Heart Fail Rev 2012; 17: 589-595.
27. Tyson CC, Nwankwo C, Lin PH, et al. The dietary approaches to stop hypertension (DASH) eating pattern in special populations. Curr Hypertens Rep 2012; 14: 388-396.
28. Azad N, Bouchard K, Mayhew A, et al. Predicting attendance factors and safety of a rehabilitation programme for elderly women with congestive heart failure. J Geriatr Cardiol 2012; 9: 243-246.
29. Mentz RJ, Schulte PJ, Fleg JL, et al. Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from heart failure and a controlled trial investigating outcomes of exercise TraiNing (HF-ACTION). Amer Heart J 2013; 165: 193-199.
30. Middlekauff HR. Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure. Circ Heart Fail 2010; 3: 537-546.
31. Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharma-codynamics: basic principles and practical applications. Br J Clin Pharmacol 2004; 57: 6-14.
32. Gastelurrutia P, Benrimoj SI, Espejo J, et al. Negative clinical outcomes asssociated with drug-related problems in heart failure (HF) outpatients: impact of a pharmacist in a mulitdisciplinary HF clinic. J of Card Fail 2011; 17: 217-223.
33. Van der Wal MH, Jaarsma T, van Veldhuisen DJ. Non-compliance in patients with heart failure; how can we manage it? Eur J Heart Fail 2005; 7: 5-17.
34. Afilalo J, Alexander KP, Macl M J, et al. Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol 2014; 63: 746-762.
35. Fonarow GC. ADHERE Scientific Advisory Committee. The acute decompensated heart failure national registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med 2003; 4 (Suppl 7): S21-S30.
36. Rich MW, McSherry F, Williford WO, et al. Digitalis investigation group. Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study. J Am Coll Cardiol 2001; 38: 806-813.
37. Hanratty CG, McGlinchey P, Johnston GD, et al. Differential pharmacokinetics of digoxin in elderly patients. Drugs Ageing 2000; 17: 353-362.
38. Hauptman PJ, McCann P, Romero JMR, et al. Reference laboratory values for digoxin following publication of digitalis investigation group (DIG) trial data. JAMA Int Med 2013; 173: 1552-1553.
39. Flather MD, Yusuf S, Køber L, Pfeffer M, et al. Long-term ACE-inhibiotr therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. Lancet 2000; 355: 1575.
40. Pfeffer MA, Swedberg K, Granger CB, et al. for the CHARM investigators and committes. Effect of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 2003; 362: 759-766.
41. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341: 709-717.
42. Juurlink DN, Mamdani MM, Lee DS, et al. Rates of hyperkalemia after publication of the randomized aldactone evaluation study. N Engl J Med 2004; 351: 543-551.
43. Braunstein GD. Clinical practice. Gynecomastia. N Engl J Med 2007; 357: 1229-1237.
44. Dobre D, van Veldhuisen DJ, DeJongste MJL, et al. Prescription of beta-blockers in patients with advanced heart failure and preserved left ventricular ejection fraction. Clinical implications and survival. Eur J Heart Fail 2007; 9: 280-286.
45. Moore AR, O'Keeffe TO. Drug-induced cognitive impairment in the elderly. Drugs Aging 1999; 15: 15-28.
46. Flather MD, Shibata MC, Coats AJ, et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005; 26: 215-225.
47. Byszewski A, Azad N, Molnar FJ, et al. Clinical pathways: adherence issues in complex older female patients with heart failure (HF). Arch Gerontol Geriatr 2010; 50: 165-170.
48. Azad N, Molnar FJ, Byszewski AM. Lessons learned from a multidisciplinary heart failure clinic for older women: A randomised controlled trial. Age and Ageing 2008; 37: 15.
49. Bardy GH, Lee KL, Mark DB, et al. Sudden cardiac death in heart failure trial (SCD-HeFT) investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.
50. Santangeli P, Di Biase L, Dello Russo A, et al. Meta-analysis: age and effectiveness of prophylactic implantable cardioverter-defibrillators. Ann Intern Med 2010; 153: 592-599.
51. Jeevanatham V, Daubert JP, Zarêba W, et al. Cardiac resynchronization therapy in heart failure patients: an update. Cardiac J 2009; 16: 197-209.
52. Veazie PJ, Noyes K, Li Q, et al. Cardiac resynchronization and quality of life in patients with minimally symptomatic heart failre. J Am Coll Cardiology 2012; 60: 1940-1944.
53. Iacoviello M, Antoncecchi V. Heart failure in elderly: progress in clinical evaluation and therapeutic approach. J Geriatr Cardiol 2013; 10: 165-177.
54. Lemay G, Azad N, Struther C. The utilization of telehome monitoring in patients 75 Years of age and over with complex heart failure; Does age make any difference? J Telemed Telecare 2013; 19: 18-22.
55. Jaarsma T, Beattie JM, Ryder M, et al. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2009; 11: 433-443.
56. Brunner-La Rocca1 H-P, Rickenbacher P, Stefano Muzzarelli S, et al. End-of-life preferences of elderly patients with chronic heart failure. Eur Heart J 2012; 33: 752-759.
57. Afilalo J, Alexander KP, Mack MJ, et al. Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiology 2014; 63: 747-762.
58. Lupón J, González B, Santaeugenia S, et al. Prognostic implication of frailty and depressive symptoms in an outpatient population with heart failure. Rev Esp Cardiol 2008; 61: 835-842.
59. Goodlin SJ. Palliative care in congestive heart failure. J Am Coll Cardiology 2009; 54: 386-396.